Literature DB >> 12359137

Seventeen novel mutations that cause profound biotinidase deficiency.

B Wolf1, K Jensen, G Hüner, M Demirkol, T Baykal, P Divry, M-O Rolland, C Perez-Cerdá, M Ugarte, R Straussberg, L Basel-Vanagaite, E R Baumgartner, T Suormala, S Scholl, A M Das, S Schweitzer, E Pronicka, J Sykut-Cegielska.   

Abstract

We report 17 novel mutations that cause profound biotinidase deficiency. Six of the mutations are due to deletions, whereas the remaining 11 mutations are missense mutations located throughout the gene and encode amino acids that are conserved in mammals. Our results increase the total number of different mutations that cause biotinidase deficiency to 79. These additional mutations will undoubtedly be helpful in identifying structure/function relationships once the three-dimensional structure of biotinidase is determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359137     DOI: 10.1016/s1096-7192(02)00149-x

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations.

Authors:  Rachel C Wiltink; Michelle E Kruijshaar; Rick van Minkelen; Willem Onkenhout; Frans W Verheijen; Evelien A Kemper; Francjan J van Spronsen; Ans T van der Ploeg; Klary E Niezen-Koning; Jasper J Saris; Monique Williams
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

2.  Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening.

Authors:  Mehmet Karaca; Rıza Köksal Özgül; Özlem Ünal; Didem Yücel-Yılmaz; Mustafa Kılıç; Burcu Hişmi; Ayşegül Tokatlı; Turgay Coşkun; Ali Dursun; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2015-03-11       Impact factor: 3.183

3.  K4, K9 and K18 in human histone H3 are targets for biotinylation by biotinidase.

Authors:  Keyna Kobza; Gabriela Camporeale; Brian Rueckert; Alice Kueh; Jacob B Griffin; Gautam Sarath; Janos Zempleni
Journal:  FEBS J       Date:  2005-08       Impact factor: 5.542

4.  Molecular Background and Disease Prevalence of Biotinidase Deficiency in a Polish Population-Data Based on the National Newborn Screening Programme.

Authors:  Aleksandra Jezela-Stanek; Lidia Suchoń; Agnieszka Sobczyńska-Tomaszewska; Kamila Czerska; Katarzyna Kuśmierska; Joanna Taybert; Mariusz Ołtarzewski; Jolanta Sykut-Cegielska
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

5.  Neonatal screening for biotinidase deficiency in Hungary: clinical, biochemical and molecular studies.

Authors:  A László; E A Schuler; E Sallay; E Endreffy; Cs Somogyi; A Várkonyi; Z Havass; K P Jansen; B Wolf
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Biotin and biotinidase deficiency.

Authors:  Janos Zempleni; Yousef I Hassan; Subhashinee Sk Wijeratne
Journal:  Expert Rev Endocrinol Metab       Date:  2008-11-01

7.  Outcomes of oral biotin treatment in patients with biotinidase deficiency - Twenty years follow-up.

Authors:  Edyta Szymańska; Małgorzata Średzińska; Agnieszka Ługowska; Magdalena Pajdowska; Dariusz Rokicki; Anna Tylki-Szymańska
Journal:  Mol Genet Metab Rep       Date:  2015-10-06

8.  Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients.

Authors:  Taciane Borsatto; Fernanda Sperb-Ludwig; Samyra E Lima; Maria R S Carvalho; Pablo A S Fonseca; José S Camelo; Erlane M Ribeiro; Paula F V de Medeiros; Charles M Lourenço; Carolina F M de Souza; Raquel Boy; Têmis M Félix; Camila M Bittar; Louise L C Pinto; Eurico C Neto; Henk J Blom; Ida V D Schwartz
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

9.  Biotinidase Deficiency: New Directions and Practical Concerns.

Authors:  Barry Wolf
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

10.  Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients.

Authors:  Taciane Borsatto; Fernanda Sperb-Ludwig; Louise L C Pinto; Gisele R De Luca; Francisca L Carvalho; Carolina F M De Souza; Paula F V De Medeiros; Charles M Lourenço; Reinaldo Lo Filho; Eurico C Neto; Pricila Bernardi; Sandra Leistner-Segal; Ida V Schwartz
Journal:  BMC Med Genet       Date:  2014-09-01       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.